/8導(dǎo)讀新冠病毒爆發(fā)以來，衛(wèi)健委及世界各國一直致力于研究有效治療的藥物。官方證實抗瘧藥物磷酸氯喹是對新冠病毒有效的。閱讀理解AntimalarialdrugconfirmedeffectiveonCOVID-19:officialChineseexperts,1._____（base）ontheresultofclinicaltrials,haveconfirmedthatChloroquinePhosphate(磷酸氯喹),anantimalarialdrug,hasacertaincurativeeffectonthenovelcoronavirusdisease(COVID-19),aChineseofficialsaidhereMonday.Theexpertshave"unanimously"suggestedthedrug2._____（include）inthenextversionofthetreatmentguidelinesandappliedinwiderclinicaltrialsassoonaspossible,SunYanrong,deputyheadoftheChinaNationalCenterforBiotechnologyDevelopmentundertheMinistryofScienceandTechnology(MOST),saidatapressconference.ChloroquinePhosphate,3._____hasbeenusedformorethan70years,wasselectedfromtensofthousandsofexistingdrugsaftermultipleroundsofscreening,Sunsaid.Accordingto4._____（she）,thedrughasbeenunderclinical5._____（trial）inover10hospitalsinBeijing,aswellasinsouthChina'sGuangdongProvinceandcentralChina'sHunanProvince,andhasshownfairlygoodefficacy.Inthetrials,thegroupsofpatients6._____hadtakenthedrughaveshownbetterindicatorsthantheirparallelgroups,inabatementoffever,improvementofCTimagesoflungs,thepercentageofpatientswhobecamenegativeinviralnucleicacidtestsandthetimetheyneedtodoso,shesaid.Patientstakingthedrugalsotakea7._____（short）timetorecover,sheadded.Sungave8._____exampleofa54-year-oldpatientinBeijing,whowasadmittedtohospitalfourdaysaftershowingsymptoms.After9._____（take）thedrugforaweek,hesawallindicatorsimproveandthenucleicacidturnnegative.Sofar,noobviousseriousadversereactionsrelatedtothedrughavebeenfound10._____theover100patientsenrolledintheclinicaltrials,shesaid.參考答案及解析：based考察非謂語動詞。本句謂語動詞為haveconfirmed。beincluded考察虛擬語氣，suggest表示建議時，從句用（should）do。which考察非限制性定語從句，先行詞ChloroquinePhosphate是一種藥物。her考察人稱代詞，做介詞的賓語需要用賓格her。trials考察名詞的數(shù)，此處為多場臨床測試。who/that考察定語從句，先行詞為人時要填who/thatshorter考察形容詞的比較級。根據(jù)語境服用該藥的患者也需要更短的時間才能康復(fù)。an考察冠詞的固定搭配，giveanexample。taking考察狀語從句中的省略。among考察介詞，“在……之間”三者、三者以上用among。專業(yè)術(shù)語積累

Antimalarialdrug抗瘧藥物COVID-192019年新冠病毒clinicaltrials臨床試驗thetreatmentguidelines治療指南ChinaNationalCenterforBiotechnologyDevelopmentundertheMinistryofScienceandTechnology(MOST)科技部中國生物技術(shù)發(fā)展中心theNationalHealthCommission國家衛(wèi)生健康委員會theNationalMedicalProductsAdministration國家藥品監(jiān)督管理局arenownedrespiratoryspecialist著名呼吸科專家長難句分析Chineseexperts,basedontheresultofclinicaltrials,haveconfirmedthatChloroquinePhosphate(磷酸氯喹),anantimalarialdrug,hasacertaincurativeeffectonthenovelcoronavirusdisease(COVID-19),aChineseofficialsaidhereMonday.句子主干：Chineseexpertshaveconfirmedthat...；其中，basedontheresultofclinicaltrials做狀語；that引導(dǎo)賓語從句中主干：ChloroquinePhosphatehasacertaincurativeeffectonthenovelcoronavirusdisease；其中，anantimalarialdrug做ChloroquinePhosphate的同位語。譯文：一位中國官員星期一在這里說，中國專家根據(jù)臨床試驗的結(jié)果證實，抗瘧藥磷酸氯喹對新型冠狀病毒?。–OVID-19）有一定療效。翻譯AntimalarialdrugconfirmedeffectiveonCOVID-19:official官方證實對COVID-19（2019年新冠病毒）有效的抗瘧藥物Chineseexperts,basedontheresultofclinicaltrials,haveconfirmedthatChloroquinePhosphate(磷酸氯喹),anantimalarialdrug,hasacertaincurativeeffectonthenovelcoronavirusdisease(COVID-19),aChineseofficialsaidhereMonday.一位中國官員星期一在這里說，中國專家根據(jù)臨床試驗的結(jié)果證實，抗瘧藥磷酸氯喹對新型冠狀病毒?。–OVID-19）有一定療效。Theexpertshave"unanimously"suggestedthedrugbeincludedinthenextversionofthetreatmentguidelinesandappliedinwiderclinicaltrialsassoonaspossible,SunYanrong,deputyheadoftheChinaNationalCenterforBiotechnologyDevelopmentundertheMinistryofScienceandTechnology(MOST),saidatapressconference.科技部中國生物技術(shù)發(fā)展中心副主任孫燕榮在新聞發(fā)布會上說，專家們“一致”建議將該藥物納入下一版本的治療指南，并盡快應(yīng)用于更廣泛的臨床試驗。ChloroquinePhosphate,whichhasbeenusedformorethan70years,wasselectedfromtensofthousandsofexistingdrugsaftermultipleroundsofscreening,Sunsaid.“氯喹磷酸鹽”已經(jīng)使用了70多年，經(jīng)過多次篩選后，從成千上萬種現(xiàn)有藥物中篩選出來。Accordingtoher,thedrughasbeenunderclinicaltrialsinover10hospitalsinBeijing,aswellasinsouthChina'sGuangdongProvinceandcentralChina'sHunanProvince,andhasshownfairlygoodefficacy.據(jù)她介紹，該藥已在北京、華南廣東省和華中湖南省的10多家醫(yī)院進行臨床試驗，并顯示出相當好的療效。Inthetrials,thegroupsofpatientswhohadtakenthedrughaveshownbetterindicatorsthantheirparallelgroups,inabatementoffever,improvementofCTimagesoflungs,thepercentageofpatientswhobecamenegativeinviralnucleicacidtestsandthetimetheyneedtodoso,shesaid.她說，在試驗中，服用該藥的患者組在退燒、肺部CT圖像改善、病毒核酸檢測呈陰性的患者百分比以及他們需要的時間等方面都顯示出比對照組更好的指標。Patientstakingthedrugalsotakeashortertimetorecover,sheadded.她補充說，服用該藥的患者也需要更短的時間才能康復(fù)。Sungaveanexampleofa54-year-oldpatientinBeijing,whowasadmittedtohospitalfourdaysaftershowingsymptoms.Aftertakingthedrugforaweek,hesawallindicatorsimproveandthenucleicacidturnnegative.孫舉了一個北京54歲的病人的例子，他在出現(xiàn)癥狀4天后入院治療。服藥一周后，他看到所有指標都有所改善，核酸轉(zhuǎn)為陰性。Sofar,noobviousseriousadversereactionsrelatedtothedrughavebeenfoundamongtheover100patientsenrolledintheclinicaltrials,shesaid.她說，到目前為止，在參加臨床試驗的100多名患者中，還沒有發(fā)現(xiàn)與該藥相關(guān)的明顯嚴重不良反應(yīng)。OnFebruary15,severaldepartmentsincludingtheMOST,theNationalHealthCommissionandtheNationalMedicalProductsAdministrationcalledavideoconferencetolistentodrugresearchandclinicalexperts'opinionsonthedrug'sefficacyonCOVID-19.2月15日，科技部、國家衛(wèi)生委員會、國家藥品監(jiān)督管理局等多個部門召開視頻會議，聽取藥物研究和臨床專家對該藥對COVID-19療效的意見。Theexpertteam,ledbyZhongNanshan,arenownedrespiratoryspecialistandanacademicianoftheChineseAcademyofEngineering,agreedthatChloroquinePhosphatecanbeusedtotreatmoreCOVID-19patients,Sunsaid.孫建華說，由著名呼吸科專家、中國工程院院士鐘南山率領(lǐng)的專家組一致認為，磷酸氯喹可用于治療更多的COVID-19患者。PreviousinvitroexperimentsshowedthatitcanblockvirusinfectionsbychangingtheacidityandbasicityvalueinsidethecellandinterferingreceptorsofSARScoronavirus.以往的體外實驗表明，通過改變細胞內(nèi)酸堿值和干擾SARS冠狀病毒受體，可以阻斷病毒感染。Italsoshowsimmune-modulatingactivity,whichmayenhanceitsantiviraleffectinvivoandiswidelydistributedinthewholebody,includingthelungs,afteroraladministration.它還具有免疫調(diào)節(jié)活性，可增強其體內(nèi)抗病毒作用，口服后廣泛分布于全身，包括肺部。拓展變形admit admits admittance admittances admitted admittedly admitting readmit readmits readmittance readmitted readmitting adverse adversely adverseness adversities adversity apply application applications applied applies applying apps